The Food and Drug Administration on Friday approved the first-ever gene-editing therapy that uses a cutting-edge technology called CRISPR to treat sickle cell disease. Dr. Jon LaPook has more.
Boeing workers going on strike after overwhelming vote to reject contract
September 13, 2024
